DERM — JOURNEY MED CORP
As of Q2 2026, 18 SEC-registered investment managers reported holding DERM (JOURNEY MED CORP) in their latest 13F filings, with a combined reported value of $8.72M across 1.23M shares. That is -57.5% by share count (-1.66M shares) versus the previous quarter, while reported value moved -35.6%. Ownership is concentrated: the five largest holders account for 64.7% of reported value and the top ten for 92.3%.
Compared with the prior quarter, 5 opened new positions, 5 added to existing stakes, 8 trimmed, 7 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
DERM is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 764.15K | $5.89M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 229.70K | $1.63M | 0.00% | Reduce |
| Geode Capital Management history | Q2 2026 | 216.00K | $1.53M | 0.00% | Reduce |
| Marshall Wace history | Q2 2026 | 139.84K | $990.09K | 0.00% | New |
| Millennium Management history | Q2 2026 | 110.02K | $778.91K | 0.00% | Reduce |
| BlackRock Inc history | Q2 2026 | 100.98K | $714.95K | 0.00% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 90.29K | $639.28K | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 83.51K | $591.28K | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 82.15K | $581.62K | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 42.02K | $297.53K | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 41.91K | $296.70K | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 35.66K | $252.44K | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q1 2026 | 45.33K | $212.60K | 0.00% | Add |
| Lazard Asset Management history | Q1 2026 | 44.90K | $210.57K | 0.00% | Reduce |
| AQR Capital Management history | Q2 2026 | 24.88K | $176.13K | 0.00% | New |
| BNY Mellon history | Q1 2026 | 37.20K | $174.44K | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 16.68K | $118.09K | 0.00% | Reduce |
| Arrowstreet Capital history | Q2 2026 | 11.30K | $80.04K | 0.00% | New |
| Royce & Associates history | Q2 2024 | 12.65K | $71.37K | 0.00% | Hold |
| Deutsche Bank AG history | Q1 2026 | 11.56K | $54.22K | 0.00% | Hold |
New Positions (Q2 2026)
- Marshall Wace 139.84K sh · $990.09K
- Citadel Advisors 82.15K sh · $581.62K
- AQR Capital Management 24.88K sh · $176.13K
- Arrowstreet Capital 11.30K sh · $80.04K
- JPMorgan Chase & Co 294 sh · $2.00K
Fully Exited (vs previous quarter)
- Charles Schwab Investment Management sold 45.33K sh · $212.60K
- Lazard Asset Management sold 44.90K sh · $210.57K
- BNY Mellon sold 37.20K sh · $174.44K
- Deutsche Bank AG sold 11.56K sh · $54.22K
- Wells Fargo & Co sold 7.50K sh · $35.18K
- Legal & General Investment Management America sold 1.80K sh · $8.45K
- T. Rowe Price Associates sold 11.21K sh · $53
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies | — | 15.60K | — | — | — | — | 11.50K | 20.90K | 261.00K | 270.60K | 264.02K | 268.20K | 236.00K | 238.00K | 243.50K | 247.90K | 244.00K | 242.50K | 229.70K |
| Geode Capital Management | — | — | — | 27.55K | 29.93K | 29.49K | 29.49K | 69.51K | 85.78K | 89.08K | 95.55K | 108.44K | 109.22K | 113.74K | 262.35K | 277.85K | 313.97K | 463.20K | 216.00K |
| Marshall Wace | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 19.40K | — | 139.84K |
| Millennium Management | — | 21.45K | — | — | — | — | — | 14.46K | 75.03K | 36.12K | — | — | — | 21.47K | — | — | 457.81K | 383.07K | 110.02K |
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | — | 52.62K | 52.74K | 53.23K | 544.34K | 633.06K | 719.78K | 972.86K | 100.98K |
| Goldman Sachs Group | 35.82K | 10.93K | — | — | — | — | — | — | — | 19.96K | — | — | — | — | — | 34.05K | 19.20K | 69.39K | 90.29K |
| UBS Group AG | 3.25K | 3.17K | 2.69K | 1.44K | — | 4.20K | 1.88K | 1.46K | 13.38K | — | — | — | 22.36K | 17.04K | 158.75K | 145.22K | 290.23K | 390.14K | 83.51K |
| Citadel Advisors | 10.76K | — | — | — | — | — | — | — | 11.36K | — | — | — | 44.57K | 49.26K | — | 14.39K | 69.42K | — | 82.15K |
| Morgan Stanley | — | — | — | — | — | — | — | — | 200 | 550 | — | — | 9.70K | 14.19K | 51.91K | 20.73K | 26.50K | 10.54K | 42.02K |
| Bank of America Corp | — | — | — | — | 14 | — | — | — | 172 | 22.66K | 71 | 82 | 82 | 86 | 4.13K | 21.54K | 10.80K | 32.21K | 41.91K |
| Northern Trust Corp | — | — | — | — | — | — | — | — | 16.65K | 17.65K | 17.65K | 17.65K | 17.26K | 17.26K | 84.99K | 92.74K | 93.67K | 149.98K | 35.66K |
| AQR Capital Management | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 50.83K | 51.27K | — | 24.88K |
| Invesco Ltd | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 16.53K | 18.50K | 16.68K |
| Arrowstreet Capital | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 11.30K |
| Citigroup Inc | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 4.31K | 519 | 326 | 1.08K | 4.07K |
| PNC Financial Services | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 74 | 41 | 1.27K |
| Fidelity Management & Research (FMR) | — | — | — | — | — | — | — | — | 128 | — | — | — | — | 2 | — | 19 | 196 | 2.19K | 476 |
| JPMorgan Chase & Co | — | — | — | — | — | — | — | 7 | 112 | 15 | 20 | 469 | — | — | 5.74K | 4.94K | 5.84K | — | 294 |
| Deutsche Bank AG | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 12.97K | — | 11.56K | 11.56K | — |
| BNY Mellon | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 24.87K | 24.49K | 28.74K | 37.20K | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details